Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis

Arthritis and Rheumatism

Volumn 65, Issue 4, 2013, Pages 911-915

  Shi, Jing ^a   Van De Stadt, Lotte A ^b   Levarht, E W Nivine ^a   Huizinga, Tom W J ^a   Toes, René E M ^a   Trouw, Leendert A ^a   Van Schaardenburg, Dirkjan ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTICLE; DISEASE CLASSIFICATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM;

ADULT; ARTHRALGIA; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CARBAMATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PRODROMAL SYMPTOMS; PROPORTIONAL HAZARDS MODELS; PROTEINS; RHEUMATOID FACTOR;

EID: 84875703131     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37830     Document Type: Article

References (15)

1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
2. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW,. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7: R949-R958.
3. Van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009; 60: 2262-71.
4. Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005; 64: 1199-204.
5. Willemze A, Trouw LA, Toes REM, Huizinga TWJ,. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol 2012; 8: 144-52.
6. Bos WH, Wolbink GJ, Boers M, Tijhuis GJ, de Vries N, van der Horst-Bruinsma IE, et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010; 69: 490-4.
7. Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, et al. The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis. Arthritis Res Ther 2010; 12: R76.
8. Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GMC, van Veelen PA, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad of Sci U S A 2011; 108: 17372-7.
9. Van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB,. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993; 20: 579-81.
10. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Gieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 1968; 37: 393-406.
11. Van de Stadt L, Bos W, Meursinge Reynders M, Wieringa H, Turkstra F, van der Laken C, et al. The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study. Arthritis Res Ther 2010; 12: R98.
12. Scherer HU, van der Woude D, Willemze A, Trouw LA, Knevel R, Syversen SW, et al. Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1461-4.
13. Van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis 2011; 70: 128-33.
14. Van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis 2010; 69: 1554-61.
15. Shi J, Willemze A, Janssen GMC, van Veelen PA, Drijfhout JW, Cerami A, et al. Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the "AMC-Senshu" method [letter]. Ann Rheum Dis 2013; 72: 148-50.